Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 2NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Rectal Neoplasms 23Colonic Neoplasms 16Colorectal Neoplasms 14Breast Neoplasms 11Stomach Neoplasms 5Pancreatic Neoplasms 5Bile Duct Neoplasms 5Unspecified Adult Solid Tumor, Protocol Specific 3Squamous Cell Carcinoma of Head and Neck 3Liver Neoplasms 3Gallbladder Neoplasms 3Breast Neoplasms, Male 3Neoplasm Metastasis 2Inflammatory Breast Neoplasms 2Head and Neck Neoplasms 2Cholangiocarcinoma 2Carcinoma, Hepatocellular 2Biliary Tract Neoplasms 2Waldenstrom Macroglobulinemia 1Turcot syndrome 1Somatostatinoma 1Sezary Syndrome 1Salivary Gland Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Pancreatic Intraductal Neoplasms 1Ovarian Neoplasms 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1

Interventions

Trastuzumab 2Streptozocin 2tipifarnib 1romidepsin 1Sorafenib 1Pantoprazole 1Oxaliplatin 1Omeprazole 1Leucovorin 1Interleukin-12 Subunit p35 1Interleukin-12 1Gefitinib 1Fluorouracil 1Floxuridine 1Doxorubicin 1Cisplatin 1Capecitabine 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Gastrinoma × Capecitabine × Clear all
NCT00602082 2013-08-07

Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors

National Cancer Institute (NCI)

Phase 2 Completed
84 enrolled
Endocrine

Glucagonoma, Insulinoma, Adenoma, Islet Cell, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡